Yahoo Finance report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.
Why BCPC Stock surged +2.72% Today — RQD Quant Desk Flash
Balchem Corporation (BCPC) earns a Roarable Rating of B- (Buy) with 71/100 RQD Confidence. High-quality cash engine (35.7% gross margin, 14% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is BCPC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, Balchem Corporation (NASDAQ: BCPC) is rated B- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 71/100 at a spot price of $174.60 (+2.72% 1D, market cap $5.40B). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 11/20, SEC Balance-Sheet Forensics 18/20, FRED Macro Regime Fit 11/20, and Executive Insider Alignment 15/20. Across 270 tracked Materials issuers, BCPC ranks #8 in composite RQD confidence.
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does BCPC compare to CE and MEOH in the Materials sector?
▼
Within the Materials sector (Major Chemicals), BCPC carries a Roarable B- (71/100 RQD), trailing P/E of 35.0x, gross margin of 35.7%, and ROIC of 14.0%. By comparison, CE (Celanese Corporation) holds a D grade (44/100 RQD, P/E N/A, ROIC -10.7%, cap $5.41B) and MEOH (Methanex Corporation) posts a C grade (65/100 RQD, P/E N/A, ROIC —, cap $5.54B). Among the 5-stock peer group, BCPC leads on earnings multiple (35.0x) while BCPC leads on capital efficiency (14.0% ROIC).
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for BCPC?
▼
Per BCPC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000009326), Balchem Corporation generated $1.04B in revenue (+8.8% YoY), $154.8M in net income, and $216.6M in free cash flow against $1.69B in total assets and $0 in total debt. Key quantitative strengths: Strong cash generator (35.7% gross margin)—profits are backed by real money, not accounting tricks. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
Altman Z-Score 9.67 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9
SEC XBRL FY 2025 (10-K): 20.9% FCF Margin ($216.6M FCF) & 35.7% Gross Margin
Macro rate sensitivity & RSI-14 (50.4) create a -9 pt regime headwind
⚔️ Adversarial Opposing Case: Why the BCPC Bull Thesis Could Fail
Even with a 71/100 (B-) score, BCPC faces multiple-compression risk if 35.0x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
Broader market pullbacks can still drag down strong stocks in the short run.
Dilution & Margin Drag: Cannibal Buyback (-2.08% YoY Shares) — any gross margin slip below 33.2% triggers an automatic RQD downgrade.
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($169.80) or 200D SMA ($169.29) invalidates the momentum regime and cuts Target Base ($184.81) toward Bear Floor ($143.17).
Why BCPC Stock surged +2.72% Today — RQD Quant Desk Flash
Balchem Corporation (BCPC) surged +2.72% to $174.60, trading at 75% of its 52-week range ($147.18 – $183.9). High-quality cash engine (35.7% gross margin, 14% return on capital) with steady institutional support.
- ▸Technical Tape: Trading at 75% of its 52-week range ($147.18 – $183.9) with RSI-14 at 50.4 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±4.5% around $174.60 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable B- (Buy) backed by 35.7% gross margin and $216.6M annual free cash flow.
Seeking Alpha report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.
ChartMill report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.
marketscreener.com report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.
Seeking Alpha report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.
StocksToTrade report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.
MONTVALE, N.J., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in Baird’s Global Industr
As inflation accelerates, WD-40, Balchem, and Interparfums show pricing power and sales resilience despite rising chemical, freight, and logistics costs pressuring margins.
Scheduled RQD Strong Buys & Whale Accumulation Briefing (BCPC Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
BCPC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +8.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on BCPC today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for BCPC. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BCPC)
1. Head-to-Head Materials Peer Comparison (BCPC vs. CE, MEOH, SXT, HXL)
Industry: Major Chemicals (67 Tracked Issuers)Across 270 tracked Materials securities in the Roarable RQD universe, Balchem Corporation (BCPC) ranks #8 by composite RQD confidence (71/100, grade B-) and #70 by equity capitalization ($5.40B). Within this direct 5-issuer industry benchmark cohort, BCPC leads on earnings valuation at 35.0x trailing P/E, while BCPC leads on capital efficiency and profitability with 14.0% ROIC and 35.7% gross margin. BCPC currently leads its immediate peer cohort in composite quantitative strength at 71/100 (B-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| BCPC
ACTIVE
Balchem Corporation | B- | 71/100 | 35.0x | 35.7% | 14.0% | +2.72% | $5.40B | Benchmark Subject |
| CE Celanese Corporation | D | 44/100 | — | 20.5% | -10.7% | -2.76% | $5.41B | /ce-vs-bcpc → |
| MEOH Methanex Corporation | C | 65/100 | — | — | — | -4.36% | $5.54B | /meoh-vs-bcpc → |
| SXT Sensient Technologies Corporation | D+ | 55/100 | 41.6x | 33.5% | 8.8% | +0.50% | $5.01B | /sxt-vs-bcpc → |
| HXL Hexcel Corporation | D | 51/100 | 55.0x | 23.0% | 6.2% | +4.34% | $5.89B | /hxl-vs-bcpc → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000009326 ↗In its most recent audited fiscal period (FY2025, filed 2025-12-31), Balchem Corporation (BCPC) reported GAAP revenue of $1.04B (+8.8% vs. FY2024 revenue of $953.7M , and +12.4% cumulative change since FY2023) , GAAP net income of $154.8M, operating cash flow of $216.6M, and free cash flow of $216.6M (+19.0% YoY). On the balance sheet, BCPC closed FY2025 with $1.69B in total assets against $0 in total debt (Altman Z-Score: 9.67, Piotroski F-Score: 8/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $1.04B | $154.8M | $216.6M | $216.6M | $1.69B | — |
| FY2024 (FY) | 2024-12-31 | $953.7M | $128.5M | $182.0M | $182.0M | $1.58B | — |
| FY2023 (FY) | 2023-12-31 | $922.4M | $108.5M | $183.8M | $183.8M | — | — |
3. BCPC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs BCPC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, Balchem Corporation (NASDAQ: BCPC) is rated B- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 71/100 at a spot price of $174.60 (+2.72% 1D, market cap $5.40B). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 11/20, SEC Balance-Sheet Forensics 18/20, FRED Macro Regime Fit 11/20, and Executive Insider Alignment 15/20. Across 270 tracked Materials issuers, BCPC ranks #8 in composite RQD confidence.
How does BCPC compare to CE and MEOH in the Materials sector?
Within the Materials sector (Major Chemicals), BCPC carries a Roarable B- (71/100 RQD), trailing P/E of 35.0x, gross margin of 35.7%, and ROIC of 14.0%. By comparison, CE (Celanese Corporation) holds a D grade (44/100 RQD, P/E N/A, ROIC -10.7%, cap $5.41B) and MEOH (Methanex Corporation) posts a C grade (65/100 RQD, P/E N/A, ROIC —, cap $5.54B). Among the 5-stock peer group, BCPC leads on earnings multiple (35.0x) while BCPC leads on capital efficiency (14.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for BCPC?
Per BCPC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000009326), Balchem Corporation generated $1.04B in revenue (+8.8% YoY), $154.8M in net income, and $216.6M in free cash flow against $1.69B in total assets and $0 in total debt. Key quantitative strengths: Strong cash generator (35.7% gross margin)—profits are backed by real money, not accounting tricks. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run. Institutional options positioning shows a 50% call / 50% put premium split.
Where is BCPC trading relative to its 50-day, 200-day, and 52-week technical levels?
BCPC last traded at $174.60 (+2.72% on volume of 168,627 shares), positioning the stock +2.83% above its 50-day simple moving average ($169.80) and +3.14% above its 200-day simple moving average ($169.29). Across its 52-week range of $147.18 to $183.90, BCPC sits at the 74.7% percentile with a 14-day RSI of 50.4 (NEUTRAL RANGE) and an implied next-earnings move of ±4.5% ($166.74 to $182.46).
BCPC — Balchem Corporation: What the Facts Mean to a Prospective Investor
1. Roarable Rating Brief: What This Means to a Prospective Investor
Balchem Corporation (BCPC) earns a live Roarable RQD composite score of 71/100, corresponding to a B- letter grade (Roarable Buy) at a spot price of $174.60 (+2.72% 1D, market capitalization $5.40B).
- Fundamental Cash Engine (16/20): Anchored by return on invested capital (ROIC) of 14.0%, gross margin of 35.7%, operating margin of 20.2%, and free cash flow yield of 4.00%.
- Whale 13F & Options Flow (11/20) + Insider Conviction (15/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
- Macro Regime Fit (11/20) + Forensic Balance Sheet (18/20): Incorporates a 1.00x equity beta, Altman Z-Score of 9.67, Piotroski F-Score of 8/9, and Debt/Equity of N/A.
2. Business Model, Unit Margins & SEC Financial Trajectory
Balchem Corporation (BCPC) is a NASDAQ-listed issuer in the Materials sector, Major Chemicals industry. The company's products, customer base, and revenue model are — Reported gross margin is 35.7%, operating margin 20.2%, and net margin 14.9% per the market data section.
In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Balchem Corporation (BCPC) reported $1.04B in annual revenue (up from $953.7M in FY2024, +8.8% YoY) and $154.8M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($922.4M revenue, $108.5M net income) through FY2025, BCPC scaled operating cash flow to $216.6M and free cash flow to $216.6M, backed by $1.69B in total assets against $0 in total debt.
3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff
- 🐂 Primary Bull Case (B- • RQD 71/100): Strong cash generator (35.7% gross margin)—profits are backed by real money, not accounting tricks. Company leadership has skin in the game with net positive insider conviction. With Fundamental Cash Engine at 16/20 and Institutional Whale Flow at 11/20, sustained execution supports upside toward the upper end of the $147.18 – $183.90 52-week range.
- 🐻 Primary Bear Case & Valuation Risk: Broader market pullbacks can still drag down strong stocks in the short run. Investors must weigh 35.0x trailing P/E and 25.5x EV/EBITDA against 20.2% operating margins and a 1.00x macro beta.
4. 2nd-Order Butterfly Ripples & Key Questions to Watch
Upstream and downstream dependencies: — Sector correlations: — Second-order bottlenecks: — Investors should watch for these relationships in future data, as the absence of mapped links means this section cannot evaluate ripple effects.
- Key Question #1: Can BCPC sustain or expand its 20.2% operating margin and 14.0% ROIC against Major Chemicals peers over the next 4 quarters?
- Key Question #2: Following FY2025 revenue of $1.04B and free cash flow of $216.6M, how will capital allocation balance growth reinvestment against $0 in total debt?
- Key Question #3: How sensitive is BCPC's 32.6x forward P/E multiple to Materials capital spending cycles and macro interest-rate shifts (Beta 1.00x)?
BCPC Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Balchem Corporation (BCPC) • Click "Debate This Headline" to argue it in the Roar Pit below
Yahoo Finance report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.
Seeking Alpha report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.
ChartMill report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.
marketscreener.com report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.
Seeking Alpha report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.
StocksToTrade report covering Balchem Corporation (BCPC) market action, institutional positioning, and fundamental catalysts.
BCPC Bull vs. Bear Conversation Board — What's Your Call at $174.60?
Forensic balance sheet scores 18/20 with Altman Z 9.67 and Piotroski F 8/9, and FY 2025 net income rose to $154.8M on $1.04B revenue.
Long BCPC at $169.98 targeting $214.17. Forensic balance sheet scores 18/20 with Altman Z 9.67 and Piotroski F 8/9, and FY 2025 net income rose to $154.8M on $1.04B revenue.. Institutional whale score is 11/20 and the risk/reward vs. the $147.18 52-week low is skewed heavily in favor of bulls.
@BearTrap_Alert Fair point on 35.0x trailing P/E, but you're ignoring the forward operating leverage in Major Chemicals. If gross margin (35.7%) holds, EPS grows into the multiple faster than bears think.
A 35x trailing P/E and 4% FCF yield leave the stock priced for growth, with the whale-flow pillar scoring only 11/20.
Fading this rally in BCPC at $169.98. A 35x trailing P/E and 4% FCF yield leave the stock priced for growth, with the whale-flow pillar scoring only 11/20.. With a beta of 1.0 and the stock sitting at $169.98 (52-wk range $147.18–$183.90), the easy multiple expansion is already priced in.